1. Home
  2. BVS vs TGE Comparison

BVS vs TGE Comparison

Compare BVS & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • TGE
  • Stock Information
  • Founded
  • BVS 2011
  • TGE 2023
  • Country
  • BVS United States
  • TGE France
  • Employees
  • BVS N/A
  • TGE N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TGE Newspapers/Magazines
  • Sector
  • BVS Health Care
  • TGE Consumer Discretionary
  • Exchange
  • BVS Nasdaq
  • TGE Nasdaq
  • Market Cap
  • BVS 496.7M
  • TGE 436.6M
  • IPO Year
  • BVS 2021
  • TGE N/A
  • Fundamental
  • Price
  • BVS $6.88
  • TGE $7.20
  • Analyst Decision
  • BVS Strong Buy
  • TGE
  • Analyst Count
  • BVS 4
  • TGE 0
  • Target Price
  • BVS $15.00
  • TGE N/A
  • AVG Volume (30 Days)
  • BVS 427.4K
  • TGE 498.6K
  • Earning Date
  • BVS 08-05-2025
  • TGE 01-01-0001
  • Dividend Yield
  • BVS N/A
  • TGE N/A
  • EPS Growth
  • BVS N/A
  • TGE N/A
  • EPS
  • BVS N/A
  • TGE 1.64
  • Revenue
  • BVS $567,699,000.00
  • TGE $77,014,000.00
  • Revenue This Year
  • BVS N/A
  • TGE N/A
  • Revenue Next Year
  • BVS $6.11
  • TGE N/A
  • P/E Ratio
  • BVS N/A
  • TGE $4.58
  • Revenue Growth
  • BVS 8.60
  • TGE 81.03
  • 52 Week Low
  • BVS $5.62
  • TGE $5.60
  • 52 Week High
  • BVS $14.38
  • TGE $37.02
  • Technical
  • Relative Strength Index (RSI)
  • BVS 53.47
  • TGE N/A
  • Support Level
  • BVS $6.52
  • TGE N/A
  • Resistance Level
  • BVS $7.21
  • TGE N/A
  • Average True Range (ATR)
  • BVS 0.28
  • TGE 0.00
  • MACD
  • BVS 0.06
  • TGE 0.00
  • Stochastic Oscillator
  • BVS 63.64
  • TGE 0.00

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About TGE The Generation Essentials Group Class A Ordinary Shares

The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.

Share on Social Networks: